A new anti-cancer strategy targets cell-surface proteins induced by conventional chemotherapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
Journal of Nanobiotechnology Open Access 07 December 2021
-
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
Journal of Nanobiotechnology Open Access 21 March 2015
-
Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticles
Scientific Reports Open Access 03 July 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rougier, P. & Lepere, C. Semin. Oncol. 32, 15–20 (2005).
Decker, S. & Sausville, E.A. Ann. NY Acad. Sci. 1059, 61–69 (2005).
Romond, E.H. et al. N. Engl. J. Med. 353, 1673–1684 (2005).
Adams, G.P. & Weiner, L.M. Nat. Biotechnol. 23, 1147–1157 (2005).
Rubinfeld, B. et al. Nat. Biotechnol. 24, 205–209 (2006).
Quak, J.J. et al. Am. J. Pathol. 136, 191–197 (1990).
de Bree, R., Roos, J.C., Verel, I., van Dongen, G.A. & Snow, G.B. Oral. Dis. 9, 241–248 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lane, D. Designer combination therapy for cancer. Nat Biotechnol 24, 163–164 (2006). https://doi.org/10.1038/nbt0206-163
Issue Date:
DOI: https://doi.org/10.1038/nbt0206-163
This article is cited by
-
Combination chemotherapy in rodents: a model for chemotherapy-induced neuropathic pain and pharmacological screening
Metabolic Brain Disease (2023)
-
Cerium oxide nanoparticles-mediated cascade catalytic chemo-photo tumor combination therapy
Nano Research (2022)
-
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
Journal of Nanobiotechnology (2021)
-
Facile Synthesis of Surfactant-Free Au Decorated Hollow Silica Nanoparticles for Photothermal Applications
Macromolecular Research (2018)
-
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
Journal of Nanobiotechnology (2015)